{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T10:36:58Z","timestamp":1781865418636,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,27]],"date-time":"2013-12-27T00:00:00Z","timestamp":1388102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s12265-013-9527-3","type":"journal-article","created":{"date-parts":[[2013,12,26]],"date-time":"2013-12-26T20:09:54Z","timestamp":1388088594000},"page":"91-100","source":"Crossref","is-referenced-by-count":84,"title":["Randomized Comparison of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome and Planned Invasive Strategy\u2014Design and Rationale of the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial"],"prefix":"10.1007","volume":"7","author":[{"name":"Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial Investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Schulz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick J.","family":"Angiolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Antoniucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabell","family":"Bernlochner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Jaitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Ludwig","family":"Laugwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"von Merzljak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Morath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz-Josef","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Richardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Ruf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Sch\u00f6mig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Sch\u00fchlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"Schunkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,27]]},"reference":[{"key":"9527_CR1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","volume":"334","author":"A Schomig","year":"1996","unstructured":"Schomig, A., Neumann, F. J., Kastrati, A., et al. (1996). A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. The New England Journal of Medicine, 334, 1084\u20131089.","journal-title":"The New England Journal of Medicine"},{"key":"9527_CR2","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"CW Hamm","year":"2011","unstructured":"Hamm, C. W., Bassand, J. P., Agewall, S., et al. (2011). ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal, 32, 2999\u20133054.","journal-title":"European Heart Journal"},{"key":"9527_CR3","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","volume":"33","author":"PG Steg","year":"2012","unstructured":"Task Force on the management of STseamiotESoC, Steg, P. G., James, S. K., et al. (2012). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal, 33, 2569\u20132619.","journal-title":"European Heart Journal"},{"key":"9527_CR4","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.jacc.2009.10.015","volume":"54","author":"FG Kushner","year":"2009","unstructured":"Kushner, F. G., Hand, M., Smith, S. C., Jr., et al. (2009). 2009 focused updates: ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC\/AHA\/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 54, 2205\u20132241.","journal-title":"Journal of the American College of Cardiology"},{"key":"9527_CR5","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","volume":"58","author":"GN Levine","year":"2011","unstructured":"Levine, G. N., Bates, E. R., Blankenship, J. C., et al. (2011). 2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Journal of the American College of Cardiology, 58, e44\u2013e122.","journal-title":"Journal of the American College of Cardiology"},{"key":"9527_CR6","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","volume":"107","author":"PA Gurbel","year":"2003","unstructured":"Gurbel, P. A., Bliden, K. P., Hiatt, B. L., & O'Connor, C. M. (2003). Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation, 107, 2908\u20132913.","journal-title":"Circulation"},{"key":"9527_CR7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jacc.2004.09.067","volume":"45","author":"VL Serebruany","year":"2005","unstructured":"Serebruany, V. L., Steinhubl, S. R., Berger, P. B., Malinin, A. I., Bhatt, D. L., & Topol, E. J. (2005). Variability in platelet responsiveness to clopidogrel among 544 individuals. Journal of the American College of Cardiology, 45, 246\u2013251.","journal-title":"Journal of the American College of Cardiology"},{"key":"9527_CR8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","volume":"56","author":"L Bonello","year":"2010","unstructured":"Bonello, L., Tantry, U. S., Marcucci, R., et al. (2010). Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. Journal of the American College of Cardiology, 56, 919\u2013933.","journal-title":"Journal of the American College of Cardiology"},{"key":"9527_CR9","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott, S. D., Braunwald, E., McCabe, C. H., et al. (2007). Prasugrel versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine, 357, 2001\u20132015.","journal-title":"New England Journal of Medicine"},{"key":"9527_CR10","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin, L., Becker, R. C., Budaj, A., et al. (2009). Ticagrelor versus clopidogrel in patients with acute coronary syndromes. The New England Journal of Medicine, 361, 1045\u20131057.","journal-title":"The New England Journal of Medicine"},{"issue":"66","key":"9527_CR11","first-page":"9","volume":"153","author":"JT Brandt","year":"2007","unstructured":"Brandt, J. T., Payne, C. D., Wiviott, S. D., et al. (2007). A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation. American Heart Journal, 153(66), 9\u201316.","journal-title":"American Heart Journal"},{"key":"9527_CR12","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","volume":"120","author":"PA Gurbel","year":"2009","unstructured":"Gurbel, P. A., Bliden, K. P., Butler, K., et al. (2009). Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study. Circulation, 120, 2577\u20132585.","journal-title":"Circulation"},{"key":"9527_CR13","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/sj.bjp.0703237","volume":"129","author":"A Sugidachi","year":"2000","unstructured":"Sugidachi, A., Asai, F., Ogawa, T., Inoue, T., & Koike, H. (2000). The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties. British Journal of Pharmacology, 129, 1439\u20131446.","journal-title":"British Journal of Pharmacology"},{"key":"9527_CR14","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","volume":"27","author":"S Husted","year":"2006","unstructured":"Husted, S., Emanuelsson, H., Heptinstall, S., Sandset, P. M., Wickens, M., & Peters, G. (2006). Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin. European Heart Journal, 27, 1038\u20131047.","journal-title":"European Heart Journal"},{"key":"9527_CR15","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/eurheartj\/ehp296","volume":"30","author":"L Wallentin","year":"2009","unstructured":"Wallentin, L. (2009). P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use. European Heart Journal, 30, 1964\u20131977.","journal-title":"European Heart Journal"},{"key":"9527_CR16","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMe0906549","volume":"361","author":"A Schomig","year":"2009","unstructured":"Schomig, A. (2009). Ticagrelor\u2014is there need for a new player in the antiplatelet-therapy field? The New England Journal of Medicine, 361, 1108\u20131111.","journal-title":"The New England Journal of Medicine"},{"key":"9527_CR17","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.109.927582","volume":"122","author":"PG Steg","year":"2010","unstructured":"Steg, P. G., James, S., Harrington, R. A., et al. (2010). Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a platelet inhibition and patient outcomes (PLATO) trial subgroup analysis. Circulation, 122, 2131\u20132141.","journal-title":"Circulation"},{"key":"9527_CR18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","volume":"373","author":"G Montalescot","year":"2009","unstructured":"Montalescot, G., Wiviott, S. D., Braunwald, E., et al. (2009). Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet, 373, 723\u2013731.","journal-title":"Lancet"},{"key":"9527_CR19","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ahj.2010.10.017","volume":"161","author":"G Montalescot","year":"2011","unstructured":"Montalescot, G., Bolognese, L., Dudek, D., et al. (2011). A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study. American Heart Journal, 161, 650\u2013656. e1.","journal-title":"American Heart Journal"},{"key":"9527_CR20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa1308075","volume":"369","author":"G Montalescot","year":"2013","unstructured":"Montalescot, G., Bolognese, L., Dudek, D., et al. (2013). Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. New England Journal of Medicine, 369, 999\u20131010.","journal-title":"New England Journal of Medicine"},{"key":"9527_CR21","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","volume":"367","author":"MT Roe","year":"2012","unstructured":"Roe, M. T., Armstrong, P. W., Fox, K. A., et al. (2012). Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. The New England Journal of Medicine, 367, 1297\u20131309.","journal-title":"The New England Journal of Medicine"},{"key":"9527_CR22","doi-asserted-by":"crossref","first-page":"d3527","DOI":"10.1136\/bmj.d3527","volume":"342","author":"SK James","year":"2011","unstructured":"James, S. K., Roe, M. T., Cannon, C. P., et al. (2011). Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial. BMJ, 342, d3527.","journal-title":"BMJ"},{"key":"9527_CR23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","volume":"57","author":"C Held","year":"2011","unstructured":"Held, C., Asenblad, N., Bassand, J. P., et al. (2011). Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. Journal of the American College of Cardiology, 57, 672\u2013684.","journal-title":"Journal of the American College of Cardiology"},{"key":"9527_CR24","first-page":"1413","volume":"2011","author":"JP Headrick","year":"1808","unstructured":"Headrick, J. P., Peart, J. N., Reichelt, M. E., & Haseler, L. J. (1808). Adenosine and its receptors in the heart: regulation, retaliation and adaptation. Biochimica et Biophysica Acta, 2011, 1413\u20131428.","journal-title":"Biochimica et Biophysica Acta"},{"key":"9527_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2010.09.017","volume":"161","author":"VL Serebruany","year":"2011","unstructured":"Serebruany, V. L. (2011). Adenosine release: a potential explanation for the benefits of ticagrelor in the PLATelet inhibition and clinical outcomes trial? American Heart Journal, 161, 1\u20134.","journal-title":"American Heart Journal"},{"key":"9527_CR26","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bbrc.2012.01.093","volume":"418","author":"J Ohman","year":"2012","unstructured":"Ohman, J., Kudira, R., Albinsson, S., Olde, B., & Erlinge, D. (2012). Ticagrelor induces adenosine triphosphate release from human red blood cells. Biochemical and Biophysical Research Communications, 418, 754\u2013758.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"II","key":"9527_CR27","first-page":"28","volume":"116","author":"KI Bj\u00f6rkman JA","year":"2007","unstructured":"Bj\u00f6rkman JA, K. I., & van Giezen, J. J. J. (2007). AZD6140 inhibits adenosine uptake into erythrocytes and enhances coronary blood flow after local ischemia or intracoronary adenosine infusion. Circulation, 116(II), 28. Abstract 245.","journal-title":"Circulation"},{"key":"9527_CR28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/1074248411410883","volume":"17","author":"JJ Giezen van","year":"2012","unstructured":"van Giezen, J. J., Sidaway, J., Glaves, P., Kirk, I., & Bjorkman, J. A. (2012). Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model. Journal of Cardiovascular Pharmacology and Therapeutics, 17, 164\u2013172.","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"7","key":"9527_CR29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jacc.2012.11.032","volume":"61","author":"A Wittfeldt","year":"2013","unstructured":"Wittfeldt, A., Emanuelsson, H., Brandrup-Wognsen, G., et al. (2013). Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans. Journal of the American College of Cardiology, 61(7), 723\u20137. doi: 10.1016\/j.jacc.2012.11.032 .","journal-title":"Journal of the American College of Cardiology"},{"key":"9527_CR30","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran, R., Rao, S. V., Bhatt, D. L., et al. (2011). Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation, 123, 2736\u20132747.","journal-title":"Circulation"},{"key":"9527_CR31","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip, D. E., Windecker, S., Mehran, R., et al. (2007). Clinical end points in coronary stent trials: a case for standardized definitions. Circulation, 115, 2344\u20132351.","journal-title":"Circulation"},{"key":"9527_CR32","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","volume":"33","author":"K Thygesen","year":"2012","unstructured":"Thygesen, K., Alpert, J. S., Jaffe, A. S., et al. (2012). Third universal definition of myocardial infarction. European Heart Journal, 33, 2551\u20132567.","journal-title":"European Heart Journal"},{"key":"9527_CR33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(13)61451-8","volume":"382","author":"SD Wiviott","year":"2013","unstructured":"Wiviott, S. D., White, H. D., Ohman, E. M., et al. (2013). Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet, 382, 605\u2013613.","journal-title":"Lancet"},{"key":"9527_CR34","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2013.02.036","volume":"61","author":"N Sarafoff","year":"2013","unstructured":"Sarafoff, N., Martischnig, A., Wealer, J., et al. (2013). Triple therapy with aspirin, prasugrel, and vitamin k antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation. Journal of the American College of Cardiology, 61, 2060\u20132066.","journal-title":"Journal of the American College of Cardiology"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-013-9527-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12265-013-9527-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-013-9527-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T06:56:28Z","timestamp":1559458588000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12265-013-9527-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,27]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["9527"],"URL":"https:\/\/doi.org\/10.1007\/s12265-013-9527-3","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,27]]}}}